PA
IPHS

Parallel Advisors’s Innophos Holdings, Inc. IPHS Stock Holding History

Parallel Advisors’s Portfolio IPHS Stock Details IPHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-266
Closed -$9K – 2788
2019
Q4 		$9K Hold
266
– – ﹤0.01% 1787
2019
Q3 		$9K Hold
266
– – ﹤0.01% 1740
2019
Q2 		$8K Hold
266
– – ﹤0.01% 1693
2019
Q1 		$8K Sell
266
-35
-12% -$1.05K ﹤0.01% 1646
2018
Q4 		$7K Buy
301
+191
+174% +$5.8K ﹤0.01% 1491
2018
Q3 		$5K Hold
110
– – ﹤0.01% 1765
2018
Q2 		$5K Hold
110
– – ﹤0.01% 1635
2018
Q1 		$4K Hold
110
– – ﹤0.01% 1674
2017
Q4 		$5K Hold
110
– – ﹤0.01% 1614
2017
Q3 		$5K Sell
110
-12
-10% -$541 ﹤0.01% 1628
2017
Q2 		$5K Buy
122
+12
+11% +$539 ﹤0.01% 1631
2017
Q1 		$5K Buy
+110
New +$5.67K ﹤0.01% 1544

Other funds holding IPHS

GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Parallel Advisors's IPHS Position: Q1 2020 in Review

Parallel Advisors sold out of Innophos Holdings, Inc. (IPHS) in Q1 2020, closing a stake of 266 shares — an estimated $9K sold.

Parallel Advisors first reported a position in IPHS in Q1 2017 and held it in 12 quarters. The position peaked at $9K in Q4 2019. 2 funds tracked by Wall St. Rank hold IPHS as of Q1 2020.

  • Parallel Advisors reported no remaining Innophos Holdings, Inc. position as of Q1 2020 after selling out during the quarter.
  • Parallel Advisors sold 266 Innophos Holdings, Inc. shares in Q1 2020, an estimated $9K.
  • Parallel Advisors first reported a position in Innophos Holdings, Inc. in Q1 2017 and held it in 12 quarters.
  • Parallel Advisors's Innophos Holdings, Inc. position peaked at $9K in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Innophos Holdings, Inc. as of Q1 2020.

Based on Parallel Advisors's 13F filing for Q1 2020, filed 27 Apr 2020.